Metraipolis › archive › dc_b4057aceeb47

Serum Gelsolin Combined with Albumin Might Be a Promising Marker for the Intensive Care Unit-Acquired Weakness-A Pilot Study — Europe PMC PMID:41828032

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41828032
DOI
10.3390/diagnostics16050758
License (as archived)
solo-consultazione
Archived
2026-11-05T04:17:35.490Z
SHA-256 of the archived text
37f3b54dd2bf5650481b36733e84ddd8690b9f428123a8d6940ee06a39ff77af
Stable URL of this page
https://metraipolis.com/documento/dc_b4057aceeb47

How to cite

Serum Gelsolin Combined with Albumin Might Be a Promising Marker for the Intensive Care Unit-Acquired Weakness-A Pilot Study — Europe PMC PMID:41828032 — Europe PMC (en), https://europepmc.org/article/MED/41828032 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b4057aceeb47 (Metraipolis archive dc_b4057aceeb47, sha256 37f3b54dd2bf5650481b36733e84ddd8690b9f428123a8d6940ee06a39ff77af)
BibTeX
@misc{dcb4057aceeb47,
  title = {Serum Gelsolin Combined with Albumin Might Be a Promising Marker for the Intensive Care Unit-Acquired Weakness-A Pilot Study — Europe PMC PMID:41828032},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41828032},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b4057aceeb47; sha256 37f3b54dd2bf5650481b36733e84ddd8690b9f428123a8d6940ee06a39ff77af},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41828032. Agents can read the archived copy with the MCP tool read_document.